Literature DB >> 18931304

The potential of desferrioxamine-gallium as an anti-Pseudomonas therapeutic agent.

Ehud Banin1, Alina Lozinski, Keith M Brady, Eduard Berenshtein, Phillip W Butterfield, Maya Moshe, Mordechai Chevion, Everett Peter Greenberg, Eyal Banin.   

Abstract

The opportunistic pathogen Pseudomonas aeruginosa causes infections that are difficult to treat by antibiotic therapy. This bacterium can cause biofilm infections where it shows tolerance to antibiotics. Here we report the novel use of a metallo-complex, desferrioxamine-gallium (DFO-Ga) that targets P. aeruginosa iron metabolism. This complex kills free-living bacteria and blocks biofilm formation. A combination of DFO-Ga and the anti-Pseudomonas antibiotic gentamicin caused massive killing of P. aeruginosa cells in mature biofilms. In a P. aeruginosa rabbit corneal infection, topical administration of DFO-Ga together with gentamicin decreased both infiltrate and final scar size by about 50% compared to topical application of gentamicin alone. The use of DFO-Ga as a Trojan horse delivery system that interferes with iron metabolism shows promise as a treatment for P. aeruginosa infections.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18931304      PMCID: PMC2575493          DOI: 10.1073/pnas.0808608105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

Review 1.  Quorum sensing signals in development of Pseudomonas aeruginosa biofilms.

Authors:  M R Parsek; E P Greenberg
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

Review 2.  Biofilm formation as microbial development.

Authors:  G O'Toole; H B Kaplan; R Kolter
Journal:  Annu Rev Microbiol       Date:  2000       Impact factor: 15.500

3.  Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?

Authors:  David M Livermore
Journal:  Clin Infect Dis       Date:  2002-01-25       Impact factor: 9.079

4.  Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials.

Authors:  A L Spoering; K Lewis
Journal:  J Bacteriol       Date:  2001-12       Impact factor: 3.490

5.  Bacterial keratitis: a prospective clinical and microbiological study.

Authors:  F Schaefer; O Bruttin; L Zografos; Y Guex-Crosier
Journal:  Br J Ophthalmol       Date:  2001-07       Impact factor: 4.638

6.  Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function.

Authors:  M Hentzer; G M Teitzel; G J Balzer; A Heydorn; S Molin; M Givskov; M R Parsek
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

7.  The push-and-pull mechanism to scavenge redox-active transition metals: a novel concept in myocardial protection.

Authors:  M Karck; S Tanaka; E Berenshtein; C Sturm; A Haverich; M Chevion
Journal:  J Thorac Cardiovasc Surg       Date:  2001-06       Impact factor: 5.209

Review 8.  Iron metabolism in pathogenic bacteria.

Authors:  C Ratledge; L G Dover
Journal:  Annu Rev Microbiol       Date:  2000       Impact factor: 15.500

Review 9.  Siderophore-antibiotic conjugates used as trojan horses against Pseudomonas aeruginosa.

Authors:  H Budzikiewicz
Journal:  Curr Top Med Chem       Date:  2001-05       Impact factor: 3.295

10.  The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity.

Authors:  Yukihiro Kaneko; Matthew Thoendel; Oyebode Olakanmi; Bradley E Britigan; Pradeep K Singh
Journal:  J Clin Invest       Date:  2007-03-15       Impact factor: 14.808

View more
  82 in total

Review 1.  Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease.

Authors:  Thaddeus J Wadas; Edward H Wong; Gary R Weisman; Carolyn J Anderson
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 2.  Applying insights from biofilm biology to drug development - can a new approach be developed?

Authors:  Thomas Bjarnsholt; Oana Ciofu; Søren Molin; Michael Givskov; Niels Høiby
Journal:  Nat Rev Drug Discov       Date:  2013-10       Impact factor: 84.694

3.  Pyochelin potentiates the inhibitory activity of gallium on Pseudomonas aeruginosa.

Authors:  Emanuela Frangipani; Carlo Bonchi; Fabrizia Minandri; Francesco Imperi; Paolo Visca
Journal:  Antimicrob Agents Chemother       Date:  2014-06-23       Impact factor: 5.191

4.  LuxS mediates iron-dependent biofilm formation, competence, and fratricide in Streptococcus pneumoniae.

Authors:  Claudia Trappetti; Adam J Potter; Adrienne W Paton; Marco R Oggioni; James C Paton
Journal:  Infect Immun       Date:  2011-08-29       Impact factor: 3.441

Review 5.  Connecting iron acquisition and biofilm formation in the ESKAPE pathogens as a strategy for combatting antibiotic resistance.

Authors:  Savannah J Post; Justin A Shapiro; William M Wuest
Journal:  Medchemcomm       Date:  2019-03-21       Impact factor: 3.597

6.  Multiple ABC transporters are involved in the acquisition of petrobactin in Bacillus anthracis.

Authors:  Shandee D Dixon; Brian K Janes; Alexandra Bourgis; Paul E Carlson; Philip C Hanna
Journal:  Mol Microbiol       Date:  2012-03-20       Impact factor: 3.501

Review 7.  Antimicrobial activity of metals: mechanisms, molecular targets and applications.

Authors:  Joseph A Lemire; Joe J Harrison; Raymond J Turner
Journal:  Nat Rev Microbiol       Date:  2013-05-13       Impact factor: 60.633

8.  Therapeutic potential of the antimicrobial peptide OH-CATH30 for antibiotic-resistant Pseudomonas aeruginosa keratitis.

Authors:  Sheng-An Li; Jie Liu; Yang Xiang; Yan-Jie Wang; Wen-Hui Lee; Yun Zhang
Journal:  Antimicrob Agents Chemother       Date:  2014-03-17       Impact factor: 5.191

9.  Niobium uptake and release by bacterial ferric ion binding protein.

Authors:  Yanbo Shi; Ian Harvey; Dominic Campopiano; Peter J Sadler
Journal:  Bioinorg Chem Appl       Date:  2010-04-28       Impact factor: 7.778

Review 10.  Jamming bacterial communication: new approaches for the treatment of infectious diseases.

Authors:  Jacqueline Njoroge; Vanessa Sperandio
Journal:  EMBO Mol Med       Date:  2009-07       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.